Skip to content

Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery

Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01189721
Enrollment
84
Registered
2010-08-27
Start date
2010-08-31
Completion date
2011-07-31
Last updated
2010-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperalgesia

Keywords

remifentanil, hyperalgesia

Brief summary

The investigators hypothesize that propofol infusion during surgery can affect the remifentanil hyperalgesia compared to sevoflurane inhalation.The outcome will be measured by a verbal numerical rating score (VNRS) and mechanical punctuating pain by electronic von frey filament.

Interventions

DRUGpropofol, sevoflurane

Remifentanil will be infused intraoperatively at 0.2 ㎍/㎏/min (group1 and 2) group 1 (Active Comparator, sevoflurane)will be infused propofol intraoperatively. group 2(Experimental, propofol) will be inhaled sevoflurane intraoperatively.

Sponsors

Gangnam Severance Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing thyroidectomy * Age 20-65 * American Society of Anesthesiologists physical status classification I or II

Exclusion criteria

* History of chronic pain, Regular use of analgesic, antiepileptic or antidepressive drugs * History of drug & alcohol abuse * Psychiatric disorder * Use of opioids within 24hrs * Renal disease with decreased glomerular filtrate ratio * Neuromuscular disease, Severe cardiac disease

Design outcomes

Primary

MeasureTime frame
Tactile pain thresholds adjacent to the surgical wound assessed by von Frey hair before the induction and at postoperative 24 & 48 hrspostoperative 48 hrs

Countries

South Korea

Contacts

Primary Contactyoung ju won, MD.
moma2@naver.com082-2-2019-6805
Backup Contactyuen hee shim, MD.
tren125@yuhs.ac082-2-2019-6808

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026